These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15002643)

  • 1. Clinical use of medical devices in the 'Bermuda Triangle'.
    Kessler L; Ramsey SD; Tunis S; Sullivan SD
    Health Aff (Millwood); 2004; 23(1):200-7. PubMed ID: 15002643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Median approval times for class III medical devices have been well above statutory deadlines set for FDA and CMS.
    Zinn AM; Allen JC; Hacker CS
    Health Aff (Millwood); 2012 Oct; 31(10):2304-13. PubMed ID: 23048112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considering changes to CMS's national coverage decision process: applying lessons learned from FDA as a regulator of access to healthcare technology.
    Zalesky CD
    Food Drug Law J; 2002; 57(1):73-93. PubMed ID: 12118482
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing efficiency: step by step.
    McGivney WT
    Physician Exec; 1991; 17(4):35-7. PubMed ID: 10112658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device manufacturers consider constraints.
    Marwick C
    JAMA; 2000 Mar; 283(11):1410-1. PubMed ID: 10732917
    [No Abstract]   [Full Text] [Related]  

  • 6. The Federal regulation of medical devices.
    Kessler DA; Pape SM; Sundwall DN
    N Engl J Med; 1987 Aug; 317(6):357-66. PubMed ID: 3299097
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the National Institutes of Health Medicare coverage assessment.
    Dubinsky M; Ferguson JH
    Int J Technol Assess Health Care; 1990; 6(3):480-8. PubMed ID: 2228460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently?
    VanAntwerp M
    J Health Care Technol; 1985; 2(2):97-103. PubMed ID: 10300492
    [No Abstract]   [Full Text] [Related]  

  • 10. New obstacles in the path of marketing new medical devices.
    Bucci VA; Reiss JB; Hall NC
    J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives. Tech coverage: "Show me the money" vs "Show me the value".
    Med Health; 2004 Nov; 58(39):1,7-8. PubMed ID: 15580965
    [No Abstract]   [Full Text] [Related]  

  • 12. Coverage with evidence development for Medicare beneficiaries: challenges and next steps.
    Daniel GW; Rubens EK; McClellan M
    JAMA Intern Med; 2013 Jul; 173(14):1281-2. PubMed ID: 23649323
    [No Abstract]   [Full Text] [Related]  

  • 13. CMS national coverage determinations for devices.
    Brock JA; Jensen TS; Jacques LB
    Health Aff (Millwood); 2013 Jan; 32(1):192. PubMed ID: 23297286
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.
    Chambers JD; May KE; Neumann PJ
    Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic imaging technologies and therapeutics devices: better information for better decisions: proceedings of a multidisciplinary workshop.
    Califf RM;
    Am Heart J; 2006 Jul; 152(1):50-8. PubMed ID: 16824831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies in technology assessment and implementation in the United States.
    Young DA
    Int J Technol Assess Health Care; 1986; 2(1):13-8. PubMed ID: 10300717
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miracles in the making.
    Wagner L
    Provider; 2003 Mar; 29(3):22-6, 28, 31-6. PubMed ID: 12666330
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the Office of Health Technology Assessment in Medicare coverage decisions.
    Marshall JE; Carter ED
    J Health Care Technol; 1986; 3(2):75-8. PubMed ID: 10301219
    [No Abstract]   [Full Text] [Related]  

  • 20. From proposal to patient: how CMS makes coverage decisions.
    Turnbull GB
    Ostomy Wound Manage; 2002 Apr; 48(4):8-10, 82. PubMed ID: 11993063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.